Immediate Impact

5 from Science/Nature 51 standout
Sub-graph 1 of 24

Citing Papers

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
6 intermediate papers

Works of Jenna Fix being referenced

RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine
2016
A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus
2015
and 1 more

Author Peers

Author Last Decade Papers Cites
Jenna Fix 428 252 97 148 19 554
Helen W. McL. Rixon 379 171 73 142 11 517
Geneviève Mottet 444 192 79 106 24 571
Richard W. Hardy 318 314 66 102 10 627
J.G. Cruickshank 289 189 118 90 26 545
Kathleen Van Wyke Coelingh 506 270 59 77 10 587
Michael B. Battles 425 254 41 98 12 578
Masfique Mehedi 225 381 50 122 22 582
Jelena Ivančić-Jelečki 231 134 47 177 33 480
Matthew Peacey 203 179 61 92 19 482
Abdul S. Yunus 378 367 74 93 24 644

All Works

Loading papers...

Rankless by CCL
2026